罗库-sugammadex作为一个替代性的肌肉松剂苏西尼尔胆在电治疗:一个元分析
Rishi Anand1,2, Deb Sanjay Nag3, Roshan Lal Gope1,2
1Department of Anaesthesiology, Tata Main Hospital, Jamshedpur 831001, Jhārkhand, India.
World journal of psychiatry
|February 5, 2026
概括
罗库-苏加马德克斯 (RS) 为电疗法 (ECT) 提供了顺胆 (SCC) 的可行替代品,显示了相似的恢复时间和更少的副作用. 需要进一步的研究来证实这些发现并评估长期结果.
科学领域:
- 麻醉学 麻醉学
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 电疗法 (ECT) 需要有效的肌肉放松.
- 顺胆 (SCC) 是常规使用的,但有不良影响.
- 罗库-苏加马德克斯 (RS) 是一种潜在的替代品,其相对有效性不确定.
研究的目的:
- 为了比较康复时间,持续时间和RS与SCC在ECT中的安全性.
- 评估这些神经肌肉阻断剂的疗效和不良事件概况.
主要方法:
- 随机和观察性研究的系统元分析.
- 在PubMed,EMBASE和Cochrane图书馆搜索到2025年6月.
- 使用随机效应模型分析了发作持续时间,恢复时间和不良事件.
主要成果:
- 复发性脊髓炎显示出较长发作持续时间的趋势,但这在RCT中并不显著.
- 在RS和SCC之间没有显著的恢复时间差异.
- 脊髓炎与肌痛等不良事件较少相关,尽管报告情况各不相同.
结论:
- 在ECT中,RS是一种可行的SCC替代品,可接受的恢复和较少的副作用.
- 与SCC相比,RS没有显著影响发作的持续时间.
- 需要更大,更高质量的RCT来确认发现并评估长期结果.
相关概念视频
Electroconvulsive Therapy
1.2K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
1.2K
Relaxation of Skeletal Muscles
5.9K
The period of muscle contraction primarily influences the duration of stimulation at the neuromuscular junction (NMJ), the presence of free calcium ions in the sarcoplasm, and the availability of energy or ATP to support contractions.
When an action potential reaches the axon terminal, it depolarizes the membrane and opens voltage-gated sodium channels. Sodium ions enter the cell, further depolarizing the presynaptic membrane. This depolarization causes voltage-gated calcium channels to open....
When an action potential reaches the axon terminal, it depolarizes the membrane and opens voltage-gated sodium channels. Sodium ions enter the cell, further depolarizing the presynaptic membrane. This depolarization causes voltage-gated calcium channels to open....
5.9K
Classification of Skeletal Muscle Relaxants
3.1K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
3.1K
Skeletal Muscle Relaxants: Therapeutic Uses
977
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
977
Skeletal Muscle Relaxants: Adverse Effects
843
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
843
Centrally Acting Muscle Relaxants: Therapeutic Uses
1.3K
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
1.3K


